Medicines, vaccines and advanced therapies

TOPIC

Medicines, vaccines and advanced therapies

Official pharmacopoeia of the Italian Republic

The quality of substances for pharmaceutical use must be assessed on the basis of continuously updated standards regarding the scientific and technological process, published in the national pharmacopoeia to guarantee their safety of use and efficacy.

For the European Union countries, the pharmacopoeia is made up of texts in force by the European Pharmacopoeia and by any national pharmacopoeias such as, in Italy, the Official Pharmacopoeia and its Secretariat.

The Secretariat is a technical structure that coordinates the activities related to the revision and elaboration of the Official Pharmacopoeia and the transposition of the European Pharmacopoeia. It also constitutes the national interface with the European Pharmacopoeia and with the European Directorate for the Quality of Medicinal Products (EDQM) for all the activities of the European Pharmacopoeia Commission and its expert groups.



Delegazione Italiana presso la Commissione Europea di Farmacopea 2020-2022

Con il Decreto del Ministro della Salute del 16 dicembre 2019 sono stati nominati membri effettivi della Delegazione Italiana presso la Commissione Europea di Farmacopea, per il triennio 2020-2022, i seguenti componenti esperti nel campo delle questioni trattate dalla Commissione stessa:

Dott.ssa Eugenia Cogliandro (AIFA)
Dott.ssa Filomena Nappi
Dott.ssa Elena Bossù

Sono nominati membri supplenti della Delegazione Italiana i seguenti componenti:
Dott. Filippo Capasso (AIFA)
Dott. Carlo Pini
Dr.ssa Christina von Hunolstein


Dipartimenti/Centri/Servizi

National Centre for Control and evaluation of medicines

Target

Citizen Healthcare professional Information specialist

Content type

Document

Topics

Medicines, vaccines and advanced therapies Official pharmacopoeia of the Italian Republic